Merck results beat expectations on strong Keytruda, Gardasil and Covid drug growth
Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid drug Lagevrio. The pharmaceutical giant also increased its full-year sales forecast to $59.7…
#hpv #merck #daiichisankyo #kelunbiotech #refinitiv #pfizer #keytruda #gardasil